Search

Search Constraints

You searched for: Author/Creator Raychaudhuri, Siba P

Search Results

3. Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study. Issue 9 (13th May 2021)

7. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Issue 6 (13th July 2012)